Health Care: Drugs

Exact Sciences Corp (EXAS: NASDAQ)

$18.625 -0.54 | -2.82%
09/22/14 - 02:26 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -46.51M -52.42M 0.00 -11.56M
Operating Gains/Losses 100.00K 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -2.89M 2.89M -263.00K 873.00K
(Decrease) Increase In Other Current Liabilities 3.31M 920.00K 1.27M 687.00K
(Increase) Decrease In Other Working Capital 2.66M 0.00 0.00 -988.00K
Other Non-Cash Items 7.74M 6.64M -24.31M 2.36M
Net Cash From Continuing Operations -39.30M -44.16M -27.82M -13.48M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -39.30M -44.16M -27.82M -13.48M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 72.29M 58.41M 46.08M 10.24M
Purchases of Property, Plant & Equipment -9.28M -681.00K -2.12M -626.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -98.51M -96.05M -87.02M -24.50M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -35.50M -38.32M -43.05M -14.88M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 74.64M 60.14M 27.90M 82.79M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -333.00K -107.00K 0.00 2.40M
Net Cash From Financing Activities 74.30M 60.04M 27.90M 85.19M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -494.00K -22.44M -42.97M 56.83M

Portfolios with EXAS

Latest EXAS Headlines from TheStreet

More Financial News for EXAS

Press Releases for EXAS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter